2008 Summary

The Mid-Atlantic Venture Association, the Virginia Biotechnology Association, and the Tech Council of Maryland/MdBio co-hosted 2008 Mid-Atlantic Bio, their signature annual bioscience industry conference, October 22-24, 2008. Over the last four years, Mid-Atlantic Bio has gained recognition as a substantive, regionally-hosted forum that attracts national and international industry leaders.

Conference attendees heard from biotech industry leaders about innovations and advances in life sciences. Investors had an opportunity to learn in depth about the initiatives of individual bioscience companies and research organizations, while exhibitors showcased their capabilities and offerings to industry stakeholders.

2008 Mid Atlantic Bio attracted more than 850 attendees from 30 states and 10 countries, including life science organizations, venture and investment firms, academic and research institutions, and government agencies. With preeminent speakers from the life sciences community, record attendance, a sold-out conference hotel, and top-tier programming, Mid-Atlantic Bio has experienced continuous growth since its inception in 2005.

Keynote speakers

Mid-Atlantic Bio consistently attracts the best and the brightest keynote speakers within the biotech field. You can expect this year's conference to live up to this tradition.

2008 Plenary speakers to include:

  • Kary Mullis, Ph.D.
    Nobel Laureate
  • The Honorable Timothy M. Kaine
    Governor of Virginia
  • Andrew C. von Eschenbach, M.D.
    Commissioner
    U.S. Food and Drug Administration
  • David M. Mott
    General Partner
    New Enterprise Associates, Inc
  • Jeremy Levin, D.Phil.
    Senior Vice President
    Bristol-Myers Squibb
  • Stuart Rothenberg
    Editor and Publisher, The Rothenberg Political Report,
    And Columnist, Roll Call

News

Baltimore-Based CSA Medical Raises $20.5 Million in Second Round

Baltimore-Based CSA Medical Raises $20.5 Million in Second Round Baltimore — CSA Medical, the Baltimore-based developer of a spray cryotherapy device that freeze and destroy unwanted tissue inside the body, said on Thursday it has raised $20.5 million in its second round of funding, co-led by Intersouth Partners and First Analysis. Other investors in the [...]

Baltimore-Based CSA Medical Raises $12.6 Million in First Round

Baltimore-Based CSA Medical Raises $12.6 Million in First Round Baltimore — CSA Medical, a Baltimore-based developer of devices that flash freeze and treat diseased tissue inside the body, said on Tuesday it has raised $12.6 million in its first round of funding, which included a new investment from Blue Heron Capital. The company, which said [...]

Rockville-Based Supernus Raises $42 Million to Prepare Drugs for Launch

Rockville-Based Supernus Raises $42 Million to Prepare Drugs for Launch Rockville, Md. — Supernus Pharmaceuticals, a Rockville-based specialty pharmaceutical firm developing treatments for disorders of the central nervous system, said on Friday it has raised $42 million through a pair of transactions. The company said it generated $27 million from the sale of its TCD [...]

Roanoke-Based PixelOptics Names Brett Craig as President and CEO

Roanoke-Based PixelOptics Names Brett Craig as President and CEO Roanoke, Va. — PixelOptics, a Roanoke-based developer of electronic focusing eyeglasses, has named Brett Craig as its new president and CEO. He succeeds Ronald Blum, who will become chief visionary officer while maintaining his role as chairman. Craig previously served as the president and COO of [...]